Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk
Description
CONCLUSION: While we have recapitulated previous findings, we conclude that the presence of the aPL, most notably PT, β2GPI, AnV IgM, and CL IgG in COVID-19 are not associated with a higher incidence of thrombotic events.